SBD L48
GENETIC COUNSELLING
16/03/2000
DR FLINTER
5 sides of handouts were supplied at the lecture, a small section of which can be found on the Virtual Campus, here.
- Reassortment of genes - individuals unique (read the Steve Jones excerpt given at lecture)
- Incidence of inherited diseases, mutation rate, role of gene defects on human pathology - triplet repeats, allelic mutations, variable deletions (frameshift theory)
- Clinical heterogeneity (variability) - penetrance, expressivity, anticipation, different alleles, different mutations.
- Risk calculation - look at the BMJ 1989 298:449-451
AUTOSOMAL DOMINANT:
- 50% risk to offspring, but consider variable penetrance and expression
- new mutations
MUTATION RATE:
Direct method of estimating mutation rate:
- proportion of new mutations determined among individuals of one generation
- only works for fully penetrant, autosomal dominant traits
- for others use indirect (algebraic) method
eg: achrondroplasia in Denmark:
94,075 births resulted in 10 achondroplastic dwarfs: 2 had affected parents, 8 had normal parents. Therefore there were 8 new mutants in 94,075 = 1 in 12,000 births, so the mutation rate per gene (gamete) is 1 in 24,000 => 42 mutations per million genes (gametes) per generation.
Calculating the carrier rate in autosomal recessive disorders: (Hardy-Weinberg principle)
AUTOSOMAL RECESSIVE:
eg: infantile polycystic kidney disease. NB: even if both parents are carriers, there is only a 1 in 4 chance of the child being affected.
INCIDENCE IN MALES OF X-LINKED DISORDERS:
- Duchenne Muscular Dystrophy (DMD) - 1 in 3000 (1/3 new mutation, 2/3 inherited from mother)
- Haemophilia - 1 in 10,000
- Fragile-X syndrome - 1 in 1000
THE ROLE OF GENE DEFECTS ON HUMAN PATHOLOGY:
Molecular phenomena - triplet repeats, allelic mutations, variable deletions (frameshift theory)
CYSTIC FIBROSIS:
- 1 in 2500 live births
- 1 in 25 North Europeans are carriers
- Most affected males are infertile because of azoospermia secondary to absence of vas deferens
- Clinical course of "typical" CF
VARIES CONSIDERABLY:
- severity of lung disease
- pancreatic sufficient or not
- sinusitis
- infertility
Some genotype/phenotype correlations:
- delta F508/delta F508 - usually severe
- non-delta F508/delta F508 - milder
- non-delta F508/non-delta F58 - milder
ie: non-delta F508 mutations are dominant to delta F508.
FACTORS CONTRIBUTING TO CLINICAL HETEROGENEITY:
- VARIABLE PENETRANCE - eg: disease which "skip" a generation. ADPKD (autosomal dominant polycystic kidney disease)
- VARIABLE EXPRESSION - eg: neurofibromatosis, tuberous sclerosis, polydactyly
- ANTICIPATION - eg: Huntington’s chorea, myotonic dystrophy
- DIFFERENT LOCI INVOLVED - eg: deafness, albinism
- EXISTENCE OF DIFFERENT DEFECTIVE ALLELES - eg: cystic fibrosis, CBAVD (congenital bilateral absence of vas deferens), Alport’s syndrome.